REMD Biotherapeutics

• Study of Healthy Aging and Physical Function With Elamipretide

  Collaborator, Phase 2, Recruiting, 30 people, 10 Dec 2025

• NCT04673617

  Phase 1/2, Completed, 45 people, 17 Dec 2020

• NCT04545411

  Collaborator, Phase 1/2, Completed, 12 people, 11 Sept 2020

Sources: clinicaltrials.gov

• Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

  Grants or research support, 11 Jan 2022

• Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

  Grants or research support, 13 Apr 2021

Sources: pubmed.ncbi.nlm.nih.gov